Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ELTX | Common Stock | Sale | -$1.54K | -374 | -1.04% | $4.13 | 35.5K | Nov 18, 2021 | Direct | F1 |
Id | Content |
---|---|
F1 | The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted on March 18, 2021 by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer. |
Senior Vice President and Chief Medical Officer